Study of a long-acting cariprazine shot for mood and schizophrenia
Part of Mental health clinical trials.
This trial tests a monthly injection of cariprazine (a medication for mental health conditions) in people who could benefit from it. It aims to see if the shot is safe, tolerable, and effective compared to taking pills every day.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have schizophrenia, bipolar I disorder, or major depression (for the first two groups).
- You are 18 to 64 years old.
- Your body mass index (BMI) is between 18.5 and 35.
- You are stable and currently taking a different antipsychotic or antidepressant medication (not cariprazine pills).
- You are willing to switch to cariprazine 3 mg per day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a long-acting injectable form of cariprazine (AX251 LAI) for people with stable schizophrenia. You would receive one injection and stay at the clinic for 7 days to see how your body handles it and how well you tolerate it.
This study tests a new extended-release injection for schizophrenia, comparing it to the existing drug Vraylar. It's for people who are currently stable on their antipsychotic medication and have tolerated oral cariprazine before.
This Phase 3 study tests whether cariprazine can improve depression symptoms in children and teens with bipolar I disorder, and also tracks side effects. It may help if your depressive episode is ongoing and you meet specific mood and screening score requirements.
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
This trial tests whether cariprazine works and is safe for teens aged 13 to 17 with schizophrenia. It may help if your symptoms are still moderate to severe despite current care.
This study tests how well a new aripiprazole injection works in your body compared to a standard version. You'll receive injections while your schizophrenia symptoms are stable, and researchers will measure drug levels in your blood to ensure the new version works the same way.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.